Stock INVA INNOVIVA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Innoviva, Inc.

Equities

INVA

US45781M1018

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
15.2 USD -1.11% Intraday chart for Innoviva, Inc. -0.39% -5.24%
04-24 Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc.?s Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024 CI
03-04 Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit MT

Evolution of the average Target Price on Innoviva, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b3e5bcf82821398e72d3336c0.GA0BAhlXVjJWNb6ONmTNcPdzS1ECUtVaif-sl_RGTD0.YjtZZihnMlAYAe_pZjW-Ip4cI2FoM4E5u8n51YMJAktTIHtAfjI1SBx_hg~9e06627806385aba635e00feb22a5608

Analyst Recommendations on Innoviva, Inc.

Morgan Stanley Adjusts Price Target on Innoviva to $10 From $13, Maintains Underweight Rating MT
Morgan Stanley Adjusts Price Target on Innoviva to $14 From $13, Maintains Underweight Rating MT
Goldman Sachs Starts Innoviva at Neutral With $16 Price Target MT
Morgan Stanley Trims Innoviva's Price Target to $12 From $13, Underweight Rating Maintained MT
Morgan Stanley Raises Innoviva's Price Target to $13 From $12, Maintains Underweight Rating MT
Morgan Stanley Raises Innoviva's Price Target to $12 From $10, Maintains Underweight Rating MT
INNOVIVA : Morgan Stanley Adjusts Innoviva PT to $10 From $8, Maintains Underweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
15.2 USD
Average target price
15 USD
Spread / Average Target
-1.32%
High Price Target
15 USD
Spread / Highest target
-1.32%
Low Price Target
15 USD
Spread / Lowest Target
-1.32%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Innoviva, Inc.

Morgan Stanley
Goldman Sachs

Ratings for Innoviva, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INVA Stock
  4. Consensus Innoviva, Inc.